The role of mode of action studies in extrapolating to human risks in toxicology.

[1]  S. Eksborg,et al.  Pharmacokinetics and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers. , 2001, British journal of clinical pharmacology.

[2]  S. Lindstedt,et al.  Nontransplant treatment of tyrosinemia. , 2000, Clinics in liver disease.

[3]  E. Lock,et al.  Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) and its effect on enzymes involved in tyrosine catabolism in the mouse. , 2000, Toxicology.

[4]  J. Styles,et al.  Chemoprevention of Breast Cancer by Tamoxifen: Risks and Opportunities , 2000, Toxicology letters.

[5]  E. Lock,et al.  Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1-3-dione (NTBC): effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat. , 1996, Toxicology and applied pharmacology.

[6]  E. Lock,et al.  Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione. , 1995, Toxicology and applied pharmacology.

[7]  T. Powles,et al.  32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifen. , 1995, Carcinogenesis.

[8]  T. Orton,et al.  Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. , 1993, Cancer research.

[9]  S. Lindstedt,et al.  Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase , 1992, The Lancet.

[10]  Lowell A. Goldsmith.  Tyrosinemia II: Lessons in Molecular Pathophysiology , 1983, Pediatric dermatology.

[11]  Adam Hk,et al.  Studies on the metabolism and pharmacokinetics of tamoxifen in normal volunteers. , 1980 .

[12]  R. Burns,et al.  Excess dietary tyrosine and corneal lesions. , 1973, Experimental eye research.

[13]  W. Aldridge.  The biological basis and measurement of thresholds. , 1986, Annual review of pharmacology and toxicology.

[14]  W. Aldridge.  Mechanisms of toxicity: New concepts are required in toxicology , 1981 .